Lymphoma, T-Cell, Peripheral

Oncology
2
Pipeline Programs
4
Companies
4
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Chipscreen Biosciences
Chipscreen BiosciencesChina - Shenzhen
1 program
1
CHOPPhase 31 trial
Active Trials
NCT06947967RecruitingEst. Dec 2032
E
EisaiChina - Liaoning
2 programs
1
Denileukin diftitoxPhase 21 trial
RemitoroN/A1 trial
Active Trials
NCT05137847Completed118Est. Mar 2023
NCT00211185Completed49Est. Dec 2009
T-Therapeutics
T-TherapeuticsUK - Cambridge
1 program
T-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell LymphomaN/A1 trial
Active Trials
NCT01142674CompletedEst. Dec 2018

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Chipscreen BiosciencesCHOP
EisaiDenileukin diftitox
EisaiRemitoro
T-TherapeuticsT-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma

Clinical Trials (4)

Total enrollment: 167 patients across 4 trials

NCT06947967Chipscreen BiosciencesCHOP

Tucidinostat in Combination With CHOP in Newly Diagnosed Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype

Start: Aug 2025Est. completion: Dec 2032
Phase 3Recruiting
NCT00211185EisaiDenileukin diftitox

A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma

Start: Mar 2004Est. completion: Dec 200949 patients
Phase 2Completed
NCT05137847EisaiRemitoro

A Study of Remitoro in Participants With Recurrent or Refractory Peripheral T Cell Lymphoma and Cutaneous T Cell Lymphoma (All Case Study)

Start: May 2021Est. completion: Mar 2023118 patients
N/ACompleted
NCT01142674T-TherapeuticsT-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma

T-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma

Start: Sep 2006Est. completion: Dec 2018
N/ACompleted

Related Jobs in Oncology

Senior Research Associate, Immuno-Oncology

SystImmune
1h ago
$60K - $85K/yr

Research Associate I/II, Immuno-Oncology

SystImmune
1h ago

Office Administrator

SystImmune
1h ago
$60K - $80K/yr

Scientist/Sr Scientist

TwoStep Therapeutics
San Carlos
1h ago

Senior Medical Project Manager (m/f/d)

Mindpeak
Hamburg
1h ago

Working Student Active Sourcing Support (m/f/d)

Mindpeak
Hamburg
1h ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
1 actively recruiting trials targeting 167 patients
4 companies competing in this space

Related Indications

Breast Cancer(530)Non-small Cell Lung Cancer(373)Prostate Cancer(371)Multiple Myeloma(244)Advanced Solid Tumors(221)Acute Myeloid Leukemia(204)Cancer(187)Neoplasms(173)Colorectal Cancer(166)Advanced Solid Tumor(165)